Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3500751018 | Lamivudine 150 mg and zidovudine 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3680039012 | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46700001000001116 | Zidovudine 300mg / Lamivudine 150mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing lamivudine and zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing lamivudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Lamivudine + zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing lamivudine and zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing zidovudine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing lamivudine and zidovudine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Lamivudine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Zidovudine | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Zidovudine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Zidovudine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing only lamivudine and zidovudine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Zidovudine + Lamivudine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has specific active ingredient | Zidovudine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has specific active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lamivudine+zidovudine 150mg/300mg tablet - product | Is a | False | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Combivir tablets (GlaxoSmithKline) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets 60 tablet | Is pack of | False | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets 60 tablet | Has VMP | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Combivir 150mg/300mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets (Teva UK Ltd) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets (Milpharm Ltd) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) | Is a | True | Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR